Showing results (61-70 of 510) with videos related to
Sort By:
Pageof 51
Journal of Blood Medicine|June 21, 2021
Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of LifeKanwaldeep K Mallhi, Aleksandra Petrovic, Hans D OchsEmerging Topics in Life Sciences|February 1, 2021
Genome editing for blood disorders: state of the art and recent advancesMarianna Romito, Rajeev Rai, Adrian J Thrasher, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2025
Ex vivo modification of hematopoietic stem and progenitor cells for gene therapyDavid A Williams, Donald B Kohn, Adrian J ThrasherOncoimmunology|July 30, 2013
Catechins and antitumor immunity: Not MDSC's cup of teaGiorgia Santilli, John Anderson, Adrian J Thrasher, et al.Frontiers in Genome Editing|October 29, 2021
Gene Editing and Genotoxicity: Targeting the Off-TargetsGeorges Blattner, Alessia Cavazza, Adrian J Thrasher, et al.Immunological Reviews|January 22, 2005
FOXP3 acts as a rheostat of the immune responseHans D Ochs, Steven F Ziegler, Troy R TorgersonCurrent Opinion in Hematology|November 29, 2007
Wiskott-Aldrich syndromeLuigi D Notarangelo, Carol H Miao, Hans D OchsCurrent Opinion in Hematology|November 16, 2010
Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndromeMichael H Albert, Luigi D Notarangelo, Hans D OchsClinical Immunology (Orlando, Fla.)|August 19, 2003
Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgMYuhui Shi, Kazunaga Agematsu, Hans D Ochs, et al.Current Opinion in Allergy and Clinical Immunology|November 3, 2005
WASP and the phenotypic range associated with deficiencyLuigi D Notarangelo, Lucia D Notarangelo, Hans D OchsPageof 51